Please do not adjust margins
ChemComm
Page 4 of 4
DOI: 10.1039/C6CC05168E
COMMUNICATION
Journal Name
9.
a) V. Bernard-Gauthier, J. J. Bailey, Z. Liu, B. Wangler, C.
Wangler, K. Jurkschat, D. M. Perrin and R. Schirrmacher,
Bioconjugate Chem., 2016, 27, 267-279; b) Z. Liu, K. S. Lin,
F. Benard, M. Pourghiasian, D. O. Kiesewetter, D. M.
Perrin and X. Chen, Nat. Protoc., 2015, 10, 1423-1432; c)
D. M. Perrin, Acc. Chem. Res., 2016, DOI:
yield from
procedure.23
6 compares similarly with the conventional
10.1021/acs.accounts.5b00398;
d)
S.
Litau,
S.
Niedermoser, N. Vogler, M. Roscher, R. Schirrmacher, G.
Fricker, B. Wangler and C. Wangler, Bioconjugate Chem.,
2015, 26, 2350-2359; e) K. Chansaenpak, B. Vabre and F.
P. Gabbai, Chem. Soc. Rev., 2016, 45, 954-971; f) L. O.
Dialer, S. V. Selivanova, C. J. Muller, A. Muller, T. Stellfeld,
K. Graham, L. M. Dinkelborg, S. D. Kramer, R. Schibli, M.
Reiher and S. M. Ametamey, J. Med. Chem., 2013, 56,
7552-7563; g) K. L. Chatalic, G. M. Franssen, W. M. van
Weerden, W. J. McBride, P. Laverman, E. de Blois, B.
Hajjaj, L. Brunel, D. M. Goldenberg, J. A. Fehrentz, J.
Martinez, O. C. Boerman and M. de Jong, J. Nucl. Med.,
2014, 55, 2050-2056.
a) M. H. Lee, T. Agou, J. Kobayashi, T. Kawashima and F. P.
Gabbai, Chem. Commun., 2007, 1133-1135; b) T. W.
Hudnall and F. P. Gabbai, J. Am. Chem. Soc., 2007, 129,
11978-11986; c) T. W. Hudnall, Y. M. Kim, M. W.
Bebbington, D. Bourissou and F. P. Gabbai, J. Am. Chem.
Soc., 2008, 130, 10890-10891; d) Y. Kim and F. P. Gabbai,
J. Am. Chem. Soc., 2009, 131, 3363-3369.
Figure 2: [18F]-setoperone accessed by trapping-release approach.
In conclusion, we have established an efficient and
reproducible preparation of reactive [18F]-fluoride directly
from aqueous mixture without azeotropic distillation via a
capture/release strategy using phosphonium borane 3+. The
so-obtained [18F]-fluoride source was efficiently engaged in
aromatic nucleophilic substitutions demonstrating that this
approach successfully overcomes the need for azeotropic
distillation. Furthermore implementation of a cartridge-based
technology brings a user-friendly and time-saving method for
the production of [18F]-fluoride ready for use. A scope
development and further solid support–strategies are
currently underway.
10.
Financial support from ANR (ANR-12-BS07-0005-01), the
Cancer Prevention Research Institute of Texas (RP130604) and
the DPST project under Royal Thai Government (K.C.) for 11.
12.
H. Zhao and F. P. Gabbai, Org. Lett., 2011, 13, 1444-1446.
C. Bresner, C. J. E. Haynes, D. A. Addy, A. E. J.
Broomsgrove, P. Fitzpatrick, D. Vidovic, A. L. Thompson, I.
A. Fallis and S. Aldridge, New J. Chem., 2010, 34, 1652-
1659.
financial support and technical support from the LCC & ICT
scientific services are acknowledged.
13.
Alternatively, reaction of 3+ with TBACN in MeCN for 15
min at rt also led to quantitative conversion to 3-CN, as it
could be observed by 11B NMR.
Notes and references
1.
a) M.-C. Lasne, C. Perrio, J. Rouden, L. Barré, D. Roeda, F.
Dollé and C. Crouzel, Top. Curr. Chem., 2002, 222, 201-
258; b) S. Preshlock, M. Tredwell and V. Gouverneur,
Chem. Rev., 2016, 116, 719-766; c) M. G. Campbell and T.
Ritter, Chem. Rev., 2015, 115, 612-633.
14.
15.
16.
Crystallographic data have been deposited to the
Cambridge Crystallographic Data Centre as CCDC 1472439
This distance correspond to a 0.7% difference to the mean
distance value analyzed in CSD.
2.
3.
D. J. Schlyer, M. A. V. Bastos, D. Alexoff and A. P. Wolf,
App. Radiat. Isotopes, 1990, 41, 531-533.
The mean angle analyzed in the CSD for
triarylcyanoborate is 175.91° and the smallest angle
reported is 170.85°.
The nature of an azeotrope obviously prevents azeotropic
distillation to fully remove the water from the solution;
Thus azeotropic distillation removes most of the water,
but the amount of remaining water can not be assessed
during radiofluorination processes.
-
17.
18.
The characteristic peaks of BF4 appear at δ(11B) -1.2, and
δ(19F) -152.3 ppm.
a) H. Sun and S. G. DiMagno, Angew. Chem. Int. Ed., 2006,
45, 2720-2725; b) H. Sun and S. G. DiMagno, J. Am. Chem.
Soc., 2005, 127, 2050-2051.
4.
5.
6.
C. F. Lemaire, J. J. Aerts, S. Voccia, L. C. Libert, F. Mercier,
D. Goblet, A. R. Plenevaux and A. J. Luxen, Angew. Chem.
Int. Ed. Engl., 2010, 49, 3161-3164.
S. A. Toorongian, G. K. Mulholland, D. M. Jewett, M. A.
Bachelor and M. R. Kilbourn, Int. J. Rad. Appl. Instrum. B,
1990, 17, 273-279.
a) J. Aerts, S. Voccia, C. Lemaire, F. Giacomelli, D. Goblet,
D. Thonon, A. R. Plenevaux, G. Warnock and A. J. Luxen,
Tetrahedron Lett., 2010, 51, 64-66; b) D. M. Jewett, S. A.
Toorongian, G. K. Mulholland, G. L. Watkins and M. R.
Kilbourn, Int. J. Rad. Appl. Instrum. A, 1988, 39, 1109-
1111.
19.
20.
Aliphatic radiofluorinations proved so far less efficient.
Using 20 mg of 3-F requires 0.8 mg of cyanide prior to
complexation, far below the LD50 of free cyanide.
900 mg Sorbent per cartridge, 37-55 µm particle.
a) C.R. Di Iorio, T.J. Watkins, M.S. Dietrich, A. Cao, J.U.
Blackford, B. Rogers, M.S. Ansari, R.M. Baldwin, R. Li, R.M.
Kessler, R.M. Salomon, M. Benningfield and R.L. Cowan
Arch. Gen. Psychiatry 2012, 69, 399-409; b) L.N. Yatham,
P.F. Liddle, V. Sossi, J. Erez, N. Vafai, R.W. Lam and S.
Blinder Arch. Gen. Psychiatry 2012, 69, 601-609; c) D.Q.
Beversdorf, R.E. Nordgren, A.A. Bonab, A.J. Fischman, S.B.
Weise, D.D. Dougherty, G.J. Fetopulos, F.C. Zhou and M.L.
Bauman J. Neuropsychiatry Clin. Neurosci. 2012, 24, 191-
197
21.
22.
7.
8.
S. H. Wessmann, G. Henriksen and H.-J. Wester,
Nuklearmedizin, 2012, 51, 1-8.
S. Lindner, C. Rensch, S. Neubaur, M. Neumeier, R.
Salvamoser, V. Samper and P. Bartenstein, Chem.
Commun., 2016, 52, 729-732.
23.
C. Crouzel, M. Venet, T. Irie, G. Sanz, C. Boullais J. Label.
Compds Radiopharm. 1988, 25, 403-414.
4 | J. Name., 2012, 00, 1-4
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins